We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$1.25B
AUM Growth
-$1.13B
Cap. Flow
-$3.33B
Cap. Flow %
-267.35%
Top 10 Hldgs %
25.05%
Holding
170
New
17
Increased
44
Reduced
95
Closed
14

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.3M
2
LKQ icon
LKQ Corp
LKQ
+$27.4M
3
GILD icon
Gilead Sciences
GILD
+$12.8M
4
INTC icon
Intel
INTC
+$12.4M
5
CMPR icon
Cimpress
CMPR
+$12.2M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$1.3B
2
AMZN icon
Amazon
AMZN
+$293M
3
ICE icon
Intercontinental Exchange
ICE
+$239M
4
FDS icon
Factset
FDS
+$123M
5
AMT icon
American Tower
AMT
+$101M

Sector Composition

Rank Sector Weight
1 Healthcare 18.76%
2 Technology 18.56%
3 Industrials 15.22%
4 Consumer Discretionary 13.41%
5 Financials 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUMO
126
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.99M 0.16%
14,683
-17,407
-54% -$1.73M
PBH icon
127
Prestige Consumer Healthcare
PBH
$2.61B
$1.88M 0.15%
+39,000
New +$1.97M
OTIC
128
DELISTED
Otonomy, Inc.
OTIC
$1.88M 0.15%
103,497
-26,619
-20% -$435K
TYPE
129
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$1.87M 0.15%
84,495
-109,995
-57% -$2.39M
SNDX icon
130
Syndax Pharmaceuticals
SNDX
$1.78B
$1.87M 0.15%
123,136
+114,524
+1,330% +$1.51M
ILMN icon
131
Illumina
ILMN
$28.4B
$1.87M 0.15%
10,560
-34,880
-77% -$5.58M
BLUE
132
DELISTED
bluebird bio
BLUE
$1.86M 0.15%
2,124
-35,412
-94% -$25.7M
ATRA icon
133
Atara Biotherapeutics
ATRA
$75.7M
$1.72M 0.14%
3,219
-4,936
-61% -$2.68M
HSKA
134
DELISTED
Heska Corp
HSKA
$1.65M 0.13%
+30,300
New +$1.49M
MDSO
135
DELISTED
Medidata Solutions, Inc.
MDSO
$1.57M 0.13%
28,198
-7,690
-21% -$407K
TARA icon
136
Protara Therapeutics
TARA
$230M
$1.51M 0.12%
4,055
-8,394
-67% -$2.95M
SPWH icon
137
Sportsman's Warehouse
SPWH
$47.2M
$1.4M 0.11%
+132,700
New +$1.34M
XENT
138
DELISTED
Intersect ENT, Inc
XENT
$1.19M 0.1%
+75,000
New +$1.13M
TVRD
139
Tvardi Therapeutics
TVRD
$24.2M
$1.17M 0.09%
3,906
-12,301
-76% -$2.67M
CALD
140
DELISTED
Callidus Software, Inc.
CALD
$861K 0.07%
46,930
-469,337
-91% -$9.17M
REGN icon
141
Regeneron Pharmaceuticals
REGN
$80B
$842K 0.07%
+2,093
New +$840K
USPH icon
142
US Physical Therapy
USPH
$1.21B
$811K 0.07%
12,933
-570,535
-98% -$35.2M
DRNA
143
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$758K 0.06%
128,926
-319,032
-71% -$1.12M
EGLT
144
DELISTED
Egalet Corporation
EGLT
$728K 0.06%
95,612
+72,008
+305% +$516K
STRT icon
145
STRATTEC Security
STRT
$365M
$709K 0.06%
20,091
-328,133
-94% -$13.9M
MELI icon
146
Mercado Libre
MELI
$93B
$698K 0.06%
3,773
-145,727
-97% -$24.2M
ATYR
147
aTyr Pharma
ATYR
$49.6M
$680K 0.05%
15,268
-9,571
-39% -$414K
STN icon
148
Stantec
STN
$8.38B
$576K 0.05%
+24,508
New +$588K
EXPO icon
149
Exponent
EXPO
$3.26B
$528K 0.04%
20,692
-188,678
-90% -$4.92M
BFAM icon
150
Bright Horizons
BFAM
$3.94B
$519K 0.04%
7,760
-141,847
-95% -$9.55M
3 4 5
6
7

Similar funds

TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
BA
Boston Advisors Boston, Massachusetts $1.91B AUM 6.26% 1-Year Est. Return

Tiverton Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, Tiverton Asset Management held 170 positions worth $1.25B, down 48% from $2.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tiverton Asset Management withdrew a net $3.33B in Q3 2016, closing 14 positions and reducing 95 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $99.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tiverton Asset Management opened a new position in Cimpress worth $12.6M.

  • Tiverton Asset Management's largest Q3 2016 buy was Cimpress: 124,600 shares worth $12.6M.
  • Tiverton Asset Management added most to Apple in Q3 2016, an estimated $28.3M increase.
  • Tiverton Asset Management's biggest Q3 2016 reduction was Intuitive Surgical, cutting an estimated $1.3B.
  • Tiverton Asset Management fully exited Alphabet (Google) Class C in Q3 2016, selling an estimated $99.1M.
  • Tiverton Asset Management's ten largest holdings make up 25% of its $1.25B portfolio in Q3 2016.
  • Tiverton Asset Management opened 17 new positions and closed 14 in Q3 2016.
  • Tiverton Asset Management's portfolio value fell 48% quarter-over-quarter to $1.25B.

Based on Tiverton Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.